Soluble CD163 is associated with fibrosis in patients with HCV and HBV [32], and sCD163 levels are elevated in patients with acute-on-chronic hepatitis B liver failure and positively associated with end-stage liver disease [34]. This evidence concerns the gene CD163 and liver disorder.